Insider Ledger
PCRX insider buying and SEC filings, explained
Pacira BioSciences, Inc. · CIK 1396814
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Pacira Pharmaceuticals, Inc.; PACIRA INC; Blue Acquisition Corp
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$11K
Planned sales (10b5-1)
$2.7M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 8, 2026 | Planned (10b5-1) | Lauren Riker (Senior Vice President, Finance) sold 6,000 shares at $36.32 ($218K), marked as a 10b5-1 plan trade. Holdings down 9% to 62,284 shares. | SEC filing Filed Oct 9, 2026, 7:07 PM ET |
| Aug 17, 2026 | Planned (10b5-1) | Jonathan Slonin (Chief Medical Officer) sold 3,040 shares at $23.23 ($71K), marked as a 10b5-1 plan trade. Holdings down 1% to 216,384 shares. | SEC filing Filed Aug 18, 2026 |
| Jun 11, 2026 | Planned (10b5-1) | Lauren Riker (Senior Vice President, Finance) sold 6,115 shares at $23.50 ($144K), marked as a 10b5-1 plan trade. Holdings down 9% to 62,284 shares. | SEC filing Filed Jun 12, 2026 |
| Jun 4, 2026 | Planned (10b5-1) | Kristen Williams (Chief Administrative Officer) sold 10,259 shares at $22.27 ($228K), marked as a 10b5-1 plan trade. Holdings down 6% to 167,062 shares. | SEC filing Filed Jun 5, 2026 |
| Apr 23, 2026 | Planned (10b5-1) | Shawn Cross (CFO) sold 12,941 shares at about $25.16 ($326K), marked as a 10b5-1 plan trade. Holdings down 11% to 105,341 shares. | SEC filing Filed Apr 24, 2026 |
| Apr 20–22, 2026 | Planned (10b5-1) | Shawn Cross (CFO) sold 12,059 shares between Apr 20 and Apr 22 at about $25.09 ($303K), marked as a 10b5-1 plan trade. Holdings down 10% to 105,341 shares. | SEC filing Filed Apr 22, 2026 |
| Mar 17, 2026 | Planned (10b5-1) | Jonathan Slonin (Chief Medical Officer) sold 3,261 shares at $22.82 ($74K), marked as a 10b5-1 plan trade. Holdings down 1% to 223,640 shares. | SEC filing Filed Mar 19, 2026 |
| Mar 17, 2026 | Sale | Mark Froimson (Director) sold 500 shares at $21.81 ($11K). Holdings down 2% to 20,136 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 19, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Lauren Riker (Senior Vice President, Finance) sold 4,000 shares at about $20.81 ($83K), marked as a 10b5-1 plan trade. Holdings down 7% to 52,313 shares. | SEC filing Filed Feb 3, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Kristen Williams (Chief Administrative Officer) sold 13,137 shares at $20.53 ($270K), marked as a 10b5-1 plan trade. Holdings down 9% to 131,303 shares. | SEC filing Filed Feb 3, 2026 |
| Jan 5, 2026 | Planned (10b5-1) | Lauren Riker (Senior Vice President, Finance) sold 1,416 shares at $24.24 ($34K), marked as a 10b5-1 plan trade. Holdings down 2% to 59,064 shares. | SEC filing Filed Jan 6, 2026 |
| Dec 9–10, 2025 | Planned (10b5-1) | Shawn Cross (CFO) sold 25,000 shares between Dec 9, 2025 and Dec 10, 2025 at about $25.07 ($627K), marked as a 10b5-1 plan trade. Holdings down 31% to 56,250 shares. | SEC filing Filed Dec 11, 2025 |
| Nov 17, 2025 | Planned (10b5-1) | Jonathan Slonin (Chief Medical Officer) sold 3,960 shares at $24.09 ($95K), marked as a 10b5-1 plan trade. Holdings down 2% to 178,367 shares. | SEC filing Filed Nov 19, 2025 |
| Nov 10, 2025 | Planned (10b5-1) | Shawn Cross (CFO) sold 12,060 shares at $22.09 ($266K), marked as a 10b5-1 plan trade. Holdings down 18% to 56,250 shares. | SEC filing Filed Nov 13, 2025 |
33 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PCRX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.